Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page now displays a 403 Forbidden error, preventing access to the study record content.SummaryDifference21%

- Check45 days agoChange DetectedA new revision tag (v3.6.6) appears on the page. This indicates a minor update to the page’s version, while the study details themselves appear unchanged.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now lists a new revision—v3.6.5—superseding the previous v3.6.4, reflecting a backend or documentation update. No substantive changes to the visible content or layout are indicated by this revision.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now shows revision v3.6.4 instead of v3.6.3, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check103 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, indicating a backend/documentation update. No study details, eligibility criteria, outcomes, or visible content were altered.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.